Literature DB >> 29184699

Pancreatic non-functioning neuroendocrine tumor: a new entity genetically related to Lynch syndrome.

Anna Serracant Barrera1, Sheila Serra Pla1, Carmen María Blázquez Maña2, Rubén Carrera Salas2, Neus García Monforte1, Natalia Bejarano González1, Andreu Romaguera Monzonis1, Francisco Javier Andreu Navarro2, Maria Rosa Bella Cueto2, Francisco G Borobia1.   

Abstract

Some pancreatic neuroendocrine tumors (P-NETs) are associated with hereditary syndromes. An association between Lynch syndrome (LS) and P-NETs has been suggested, however it has not been confirmed to date. We describe the first case associating LS and P-NETs. Here we report a 65-year-old woman who in the past 20 years presented two colorectal carcinomas (CRC) endometrial carcinoma (EC), infiltrating ductal breast carcinoma, small intestine adenocarcinoma, two non-functioning P-NETs and sebomatricoma. With the exception of one P-NET, all these conditions were associated with LS, as confirmed by immunohistochemistry (IHC) and polymerase chain reaction (PCR). LS is caused by a mutation of a mismatch repair (MMR) gene which leads to a loss of expression of its protein. CRC is the most common tumor, followed by EC. Pancreatic tumors have also been associated with LS. Diagnosis of LS is based on clinical criteria (Amsterdam II and Bethesda) and genetic study (MMR gene mutation). The association between LS and our patient's tumors was confirmed by IHC (loss of expression of proteins MLH1 and its dimer PMS2) and the detection of microsatellite instability (MSI) using PCR.

Entities:  

Keywords:  Lynch syndrome (LS); immunohistochemistry (IHC); microsatellite instability (MSI); pancreatic neuroendocrine tumors (P-NETs); polymerase chain reaction (PCR)

Year:  2017        PMID: 29184699      PMCID: PMC5674252          DOI: 10.21037/jgo.2017.07.02

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  14 in total

1.  Pancreatic cancer and a novel MSH2 germline alteration.

Authors:  Noralane M Lindor; Gloria M Petersen; Amanda B Spurdle; Bryony Thompson; David E Goldgar; Stephen N Thibodeau
Journal:  Pancreas       Date:  2011-10       Impact factor: 3.327

Review 2.  Small bowel endoscopy in familial adenomatous polyposis and Lynch syndrome.

Authors:  Jan Jacob Koornstra
Journal:  Best Pract Res Clin Gastroenterol       Date:  2012-06       Impact factor: 3.043

3.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

4.  Mucinous carcinoma of the duodenum associated with hereditary nonpolyposis colorectal cancer: report of a case.

Authors:  Toshihiko Yagyu; Tsukasa Aihara; Michinori Murayama; Shoichi Kikuchi; Eisyu Nakamura; Kazuo Hase; Kazuo Hatsuse; Kazuo Tamura; Hidetaka Mochizuki
Journal:  Surg Today       Date:  2006-12-25       Impact factor: 2.549

5.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

6.  Pancreatic intraductal papillary mucinous neoplasm in a patient with Lynch syndrome.

Authors:  Meghan R Flanagan; Arjun Jayaraj; Wei Xiong; Matthew M Yeh; Wendy H Raskind; Venu G Pillarisetty
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

7.  Risk of pancreatic cancer in families with Lynch syndrome.

Authors:  Fay Kastrinos; Bhramar Mukherjee; Nabihah Tayob; Fei Wang; Jennifer Sparr; Victoria M Raymond; Prathap Bandipalliam; Elena M Stoffel; Stephen B Gruber; Sapna Syngal
Journal:  JAMA       Date:  2009-10-28       Impact factor: 56.272

Review 8.  Cancer risk in Lynch Syndrome.

Authors:  Emma Barrow; James Hill; D Gareth Evans
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

Review 9.  Management of pancreatic neuroendocrine tumors.

Authors:  Paxton V Dickson; Stephen W Behrman
Journal:  Surg Clin North Am       Date:  2013-04-03       Impact factor: 2.741

10.  Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study.

Authors:  Jae-Gahb Park; Duck-Woo Kim; Chang Won Hong; Byung-Ho Nam; Young-Kyoung Shin; Sung-Hye Hong; Il-Jin Kim; Seok-Byung Lim; Melyssa Aronson; Marie Luise Bisgaard; Gregor J Brown; John Burn; Elizabeth Chow; Peggy Conrad; Fiona Douglas; Malcolm Dunlop; James Ford; Marc S Greenblatt; Jarvinen Heikki; Karl Heinimann; Elly L Lynch; Finlay Macrae; Wendy C McKinnon; Gabriela Möeslein; Benedito Mauro Rossi; Paul Rozen; Lyn Schofield; Carlos Vaccaro; Hans Vasen; Mary Velthuizen; Alessandra Viel; Juul Wijnen
Journal:  Clin Cancer Res       Date:  2006-06-01       Impact factor: 12.531

View more
  3 in total

1.  Case Report: Grade 2 Metastatic Pancreatic Neuroendocrine Tumor With Progression of One Metastasis After Pregnancy to Grade 3 Large-Cell Neuroendocrine Carcinoma: One Case Cured by Resection With Genomic Characterization of the Two Components.

Authors:  Jean-Luc Raoul; Marie-Françoise Heymann; Frédéric Dumont; Alain Morel; Hélène Senellart; François Bertucci
Journal:  Front Oncol       Date:  2021-03-31       Impact factor: 6.244

2.  Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas.

Authors:  Christoph Fraune; Ronald Simon; Claudia Hube-Magg; Georgia Makrypidi-Fraune; Martina Kluth; Franziska Büscheck; Tania Amin; Fabrice Viol; Wilfrid Fehrle; David Dum; Doris Höflmayer; Eike Burandt; Till Sebastian Clauditz; Daniel Perez; Jakob Izbicki; Waldemar Wilczak; Guido Sauter; Stefan Steurer; Jörg Schrader
Journal:  Endocr Pathol       Date:  2020-06       Impact factor: 3.943

3.  Efficacy of neoadjuvant endocrine therapy in patients with poorly differentiated neuroendocrine carcinoma of the breast: A case report.

Authors:  Yonglin Zhang; Chao Liu; Chaoting Zheng; Qiaozhen Ren; Qimin Wang; Xinyi Gao; Yushuang He; Jierong Wu; Guanglei Chen; Xuelu Li; Zhenhai Ma
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.